AARTI DRUGS
Back to Income Statement
|
AARTI DRUGS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹171 Cr | ₹166 Cr | ₹205 Cr | ₹280 Cr | ₹141 Cr |
What is the latest Consolidated Net Profit of AARTI DRUGS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹171 Cr |
| Mar2024 | ₹166 Cr |
| Mar2023 | ₹205 Cr |
| Mar2022 | ₹280 Cr |
| Mar2021 | ₹141 Cr |
How is Consolidated Net Profit of AARTI DRUGS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹171 Cr | 3.07 | |
| Mar2024 | ₹166 Cr | -18.89 | |
| Mar2023 | ₹205 Cr | -26.88 | |
| Mar2022 | ₹280 Cr | 98.31 | |
| Mar2021 | ₹141 Cr | - | |
Compare Consolidated Net Profit of peers of AARTI DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI DRUGS | ₹3,850.1 Cr | 1.7% | 3.9% | -17.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,952.0 Cr | 1.8% | -1.6% | 16.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹230,427.0 Cr | -1.2% | 17.3% | 38.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,141.0 Cr | -2.3% | -2% | 33.6% | Stock Analytics | |
| CIPLA | ₹114,715.0 Cr | 0.2% | 1.7% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,409.9 Cr | 1.2% | 3.6% | -7% | Stock Analytics | |
AARTI DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI DRUGS | 1.7% |
3.9% |
-17.1% |
| SENSEX | 0.5% |
2.1% |
-4.5% |
You may also like the below Video Courses